OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
June 02, 2011
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Sometimes, there are just too many cooks in the kitchen.
FDA added a searchable database of inspection data to its website. The database lists the names and addresses of facilities that the agency inspected during fiscal years 2009 and 2010.
India's drug pricing authority increased the retail costs of certain domestically manufactured drugs, but not those of imported drug products. Pharma is asking why.
May 26, 2011
Global spending on medicines will total almost $1.1 trillion by 2015, according to an IMS Institute for Healthcare Informatics study.
May 05, 2011
The IPEC is soliciting public comment about a draft plan for the independent certification of manufacturers and suppliers of pharmaceutical excipients.
May 02, 2011
Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.